Medical/Pharmaceuticals

VISTA Eye Specialist unveils gaming technology for eye treatment

KUALA LUMPUR, Malaysia, Nov. 28, 2019 /PRNewswire/ -- VISTA Eye Specialist (VISTA), one of the leading Eye Specialists inMalaysia, announces the launch of a neurorehabilitation software - Vivid Vision - that uses virtual reality (VR) games to help binocular vision disorders such as lazy or squint...

2019-11-28 08:00 3634

Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050

HONG KONG, Nov. 28, 2019 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) today announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the ARCHER 1050, a randomized, multicenter, multinational, open-label Phase 3 study evaluating the efficacy of VIZIMPRO® ...

2019-11-28 00:34 8931

INC: Higher Nut Consumption May Help Prevent Cognitive Decline in the Elderly

REUS, Spain, Nov. 27, 2019 /PRNewswire/ -- A recent INC-funded study, published inMolecular Nutrition & Food Research[1], showed that a high intake of nuts may help protect the elderly from cognitive decline. Nuts and bra...

2019-11-27 23:44 3298

VUNO Presents the Future of Medical AI Solutions at RSNA 2019

CHICAGO, Nov. 27, 2019 /PRNewswire/ -- VUNO Inc., a medical AI solution developer and a member company of the Born2Global Centre, will participate in  RSNA (Radiological Society ofNorth America) 2019 in Chicago, December 1-8. Booth: North Hall Level2, #11132.

2019-11-27 21:30 1751

Golden Meditech Announces FY2019/2020 Interim Results

Revenue Fluctuated Amidst the Challenging Market Conditions Significant Increase in Revenue Noted at Beijing Sunbow Obstetrics & Gynecology Hospital HONG KONG, Nov. 27, 2019 /PRNewswire/ -- For the Six Months Ended 30 September 2019 (HK$'000) 2018 (HK$'000) Change (%) Revenue 157,2...

2019-11-27 18:52 5135

Unsafe Working Environments in the IT Industry Risk People's Health

STOCKHOLM, Nov. 27, 2019 /PRNewswire/ -- Excessive working hours, forced labor and discrimination are some of the problems that risk workers' health in the IT industry. Achieving a more socially sustainable industry requires long term investments, follow-up and clear consequences that encourage a...

2019-11-27 16:00 2168

Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-PD-1/HER2 Bispecific Antibody in China

SUZHOU, China, Nov. 27, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today ...

2019-11-27 07:50 3575

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020

HONG KONG, Nov. 27, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...

2019-11-27 05:16 11258

New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease

ABERDEEN, Scotland and SINGAPORE, Nov. 27, 2019 /PRNewswire/ -- In a paper published in today's online issue of theJournal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels ...

2019-11-27 02:31 1693

Philips Commended by Frost & Sullivan for Advancing Access to Affordable, High-quality Care through Its Incisive CT Platform

The platform empowers healthcare providers and organizations to deliver on the value-based care promise LONDON, Nov. 26, 2019 /PRNewswire/ -- Based on its recent analysis of the global computed tomography (CT) market, Frost & Sullivan recognizesRoyal Philips (Philips) with the 2019 Global Custom...

2019-11-26 22:00 1194

Japan and Singapore Grant CRISPR Patents to Merck

- Merck now holds 22 CRISPR-related patents worldwide across nine different geographies - Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research DARMSTADT, Germany, Nov. 26, 2019 /PRNewswire/ -- Merck, a leading science and technology company, to...

2019-11-26 21:00 2134

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing overUS$100B per year * Drug developers currently lack effective humanized models for preclinical testing of targeted drug candidates in heart failure with preserved ejection fraction * The c...

2019-11-26 16:31 2462

Blockchain in Healthcare Will Live Up to the Hype Versus Reality for Stakeholders

SANTA CLARA, California, Nov. 25, 2019 /PRNewswire/ -- With the healthcare industry increasingly going digital, blockchain technology provides the much-needed trust, security, and auditability for healthcare data on its intelligence journey, which allows blockchain to complement healthcare artifi...

2019-11-25 22:10 1553

Venturing into the future of healthcare with AI - SonoScape at Medica 2019

DUSSELDORF, Germany, Nov. 25, 2019 /PRNewswire/ -- SonoScape, as one of the leading providers of medical ultrasound and endoscopy solutions, presented its latest products and technologies in the world's largest medical event Medica: its first echoendoscope EG-UR5 (endoscopic ultrasound), a new 4-...

2019-11-25 20:28 1686

Xinhua Silk Road: Er-Kang highly recognized for "going global" achievements in Cambodia

PHNOM PENH, Cambodia, Nov. 25, 2019 /PRNewswire/ -- Hunan Er-Kang (Cambodia) Investment Co., Ltd., an overseas arm ofChina's Hunan Er-Kang Pharmaceutical Co., Ltd. (300267.SZ), has recently received a delegation of Communist Party led by Du Jiahao, Secretary of the CPC Hunan Provincial Committee,...

2019-11-25 18:16 1646

ActLight: Ultra Small, Very Low Power Consumption Heart Rate Monitoring Sensor for Hearables? You Need the ActLight Dynamic Photodiode

LAUSANNE, Switzerland, Nov. 25, 2019 /PRNewswire/ -- Long battery life, precision of measurements and very small size are the key requirements for vital signs monitoring sensors in hearable devices. The Dynamic PhotoDiod...

2019-11-25 08:19 2173

Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050

SINGAPORE, Nov. 25, 2019 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) today announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the ARCHER 1050, a randomized, multicenter, multinational, open-label Phase 3 study evaluating the efficacy of VIZIMPRO® ...

2019-11-25 08:15 2173

Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference

SYDNEY, Nov. 25, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share with investors interim data from its ongoing phase II study of GDC-0084 in glioblastoma, the most common and most aggressive form of...

2019-11-25 07:00 2117

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...

2019-11-23 01:55 5493

Patient Enrollment Completed in Phase III Clinical Study of Adapalene-Clindamycin Combination Gel in China

BEIJING, Nov. 22, 2019 /PRNewswire/ -- China Ophthalmology Focus Limited ("COPFL") today announced that its wholly-owned subsidiary, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited ("ZKO") has successfully completed patient enrollment of the Phase III study of Adapalene-Clindamycin Combin...

2019-11-22 23:50 3457
1 ... 598599600601602603604 ... 606